A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia.

Trial Profile

A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Mar 2016

At a glance

  • Drugs Eszopiclone (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Sunovion Pharmaceuticals
  • Most Recent Events

    • 01 Feb 2010 Results published in Sleep.
    • 09 Sep 2008 Endpoint 'Wake time after sleep onset' has been met.
    • 09 Sep 2008 Endpoint 'Sleep latency' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top